In a fluvoxamine trial of people who came down with COVID, people were offered the option to take or pass on the drug.
Despite the hurdle of people feeling sicker opting in and people feeling okay opting out, the people who opted in on fluvoxamine had better outcomes than the people who did not.
“It’s like playing tennis with two hands tied behind your back and winning!” accentuated VSRF Founder Steve Kirsch.
But even with astounding results, the FDA denied EUA for fluvoxamine. “It wasn’t a randomized trial.” Over a year later, that same FDA approved the bivalent booster tested in eight mice…
Be sure to stay up to date with the latest news on our Red Voice Media’s aggregate news homepage. You can also see all of our video content on our dedicated video page. Just want to see all of our different creator’s latest episodes? Check out our shows page. Want to see every piece of PREMIUM content all in one place? Yup, we’ve got that covered on our PREMIUM content page. Not a PREMIUM member yet? You can check it out with a ONE-DOLLAR Trial & go AD-FREE on Red Voice Media, get access to all the PREMIUM content from all of our different creators, support our Constitutional values and help keep Red Voice Media independent of any outside funding.
The opinions expressed by contributors and/or content partners are their own and do not necessarily reflect the views of Red Voice Media. Contact us for guidelines on submitting your own commentary. Red Voice Media would like to make a point of clarification on why we do not refer to any shot related to COVID-19 as a "vaccine." According to the CDC, the definition of a vaccine necessitates that said vaccine have a lasting effect of at least one year in preventing the contraction of the virus or disease it's intended to fight. Because all of the COVID-19 shots thus far available have barely offered six months of protection, and even then not absolute, Red Voice Media has made the decision hereafter to no longer refer to the Pfizer, Moderna, or Johnson & Johnson substances as vaccinations.